AI
NEUE

Accredited Investors’s NeueHealth NEUE Stock Holding History

Accredited Investors’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,733
Closed -$48.2K – 200
2023
Q1 		$48.2K Buy
2,733
+1,250
+84% +$64.4K ﹤0.01% 188
2022
Q4 		$77.1K Buy
1,483
+260
+21% +$18.9K 0.01% 183
2022
Q3 		$103K Sell
1,223
-352
-22% -$46.7K 0.01% 166
2022
Q2 		$229K Sell
1,575
-78
-5% -$11.4K 0.03% 154
2022
Q1 		$255K Buy
1,653
+296
+22% +$65.7K 0.02% 156
2021
Q4 		$373K Buy
1,357
+1,023
+306% +$472K 0.03% 131
2021
Q3 		$218K Buy
+334
New +$294K 0.02% 161

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Accredited Investors's NEUE Position: Q2 2023 in Review

Accredited Investors sold out of NeueHealth (NEUE) in Q2 2023, closing a stake of 2,733 shares — an estimated $48.2K sold.

Accredited Investors first reported a position in NEUE in Q3 2021 and held it in 7 quarters. The position peaked at $373K in Q4 2021. 49 funds tracked by Wall St. Rank hold NEUE as of Q2 2023.

  • Accredited Investors reported no remaining NeueHealth position as of Q2 2023 after selling out during the quarter.
  • Accredited Investors sold 2,733 NeueHealth shares in Q2 2023, an estimated $48.2K.
  • Accredited Investors first reported a position in NeueHealth in Q3 2021 and held it in 7 quarters.
  • Accredited Investors's NeueHealth position peaked at $373K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held NeueHealth as of Q2 2023.

Based on Accredited Investors's 13F filing for Q2 2023, filed 3 Aug 2023.